Metastatic anal cancer: The search for cure

Onkologie

Volumn 29, Issue 1-2, 2006, Pages 5-6

  Cummings, Bernard J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUOROURACIL; MITOMYCIN;

ANUS CANCER; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONVALESCENCE; EDITORIAL; HUMAN; INCIDENCE; LIVER METASTASIS; LIVER TOXICITY; LUNG METASTASIS; METASTASIS; MULTIMODALITY CANCER THERAPY; PARTIAL HEPATECTOMY; PELVIS TUMOR; PROGNOSIS; RADIATION DOSE; SALVAGE THERAPY; SURVIVAL RATE; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 33644780868     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090747     Document Type: Editorial

References (6)

1. Cummings BJ, Swallow CJ, Ajani JA: Cancer of the anal region; in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, Lippincott Williams and Wilkins, ed 7, 2005, pp 1125-1138.
2. Tokar M, Bobilev D, Zalmanov S, Geffen DB, Walfisch S: Combined multimodal approach to the treatment of metastatic anal carcinoma: Report of a case and review of the literature. Onkologie 2006; 29 DOI: 10.1159/000089798.
3. UKCCCR Anal Canal Cancer Trial Working Party. Epidermoid anal cancer: Results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin C. Lancet 1996;348:1049-1054.
4. Jaiyesimi IA, Pazdur R: Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal. Am J Clin Oncol 1993:16:536-540.
5. Le LH, Chetty R, Moore MJ: Epidermal growth factor expression in anal canal carcinoma. Am J Clin Pathol 2005;124:20-23.
6. Tepper JE, O'Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ: Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. J Clin Oncol 2003;21:3623-3628.